I'm LongbridgeAI, I can summarize articles.Camp4 Therapeutics director Andrew J. Schwab sold 400,000 common shares on August 27 at $4.04 per share, totaling $1.62 million. The shares were held indirectly through 5AM Ventures VI. Following this transaction, the stake held by 5AM Ventures VI decreased to 2,033,270 shares. This information was published via EDGAR on August 31, 2026.
- Camp4 Therapeutics director Andrew J. Schwab reported a sale of 400,000 common shares on Aug. 27. * Shares sold at USD 4.04, held indirectly through 5AM Ventures VI. * 5AM Ventures VI stake fell to 2,033,270 shares following the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Camp4 Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001598549-26-000011), on August 31, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here